Authors: Cook, EH Wagner, KD March, JS Biederman, J Landau, P Wolkow, R Messig, M

Citation: Eh. Cook et al., Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder, J AM A CHIL, 40(10), 2001, pp. 1175-1181

Authors: Rapaport, MH Pollack, MH Clary, CM Mardekian, J Wolkow, R

Citation: Mh. Rapaport et al., Panic disorder and response to sertraline: The effect of previous treatment with benzodiazepines, J CL PSYCH, 21(1), 2001, pp. 104-107

Authors: Rapaport, MH Wolkow, R Rubin, A Hackett, E Pollack, M Ota, KY

Citation: Mh. Rapaport et al., Sertraline treatment of panic disorder: results of a long-term study, ACT PSYC SC, 104(4), 2001, pp. 289-298

Authors: Pollack, MH Rapaport, MH Clary, CM Mardekian, J Wolkow, R

Citation: Mh. Pollack et al., Sertraline treatment of panic disorder: Response in patients at risk for poor outcome, J CLIN PSY, 61(12), 2000, pp. 922-927

Authors: Rapaport, MH Pollack, M Wolkow, R Mardekian, J Clary, C

Citation: Mh. Rapaport et al., Is placebo response the same as drug response in panic disorder?, AM J PSYCHI, 157(6), 2000, pp. 1014-1016

Authors: Wilens, TE Biederman, J March, JS Wolkow, R Fine, CS Millstein, RB Faraone, SV Geller, D Spencer, TJ

Citation: Te. Wilens et al., Absence of cardiovascular adverse effects of sertraline in children and adolescents, J AM A CHIL, 38(5), 1999, pp. 573-577